Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes

被引:14
作者
Fenner, Lukas [1 ]
Gagneux, Sebastien [2 ,3 ]
Janssens, Jean-Paul [4 ]
Fehr, Jan [5 ]
Cavassini, Matthias [6 ]
Hoffmann, Matthias [7 ]
Bernasconi, Enos [8 ]
Schrenzel, Jacques [9 ]
Bodmer, Thomas [10 ]
Boettger, Erik C. [11 ]
Helbling, Peter [12 ]
Egger, Matthias [1 ]
机构
[1] Univ Bern, Inst Social & Prevent Med ISPM, Bern, Switzerland
[2] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Univ Hosp Geneva, Div Pneumol, Geneva, Switzerland
[5] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland
[6] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland
[7] Kantonsspital St Gallen, Div Infect Dis, St Gallen, Switzerland
[8] Osped Reg, Div Infect Dis, Lugano, Switzerland
[9] Univ Hosp Geneva, Bacteriol Lab, Geneva, Switzerland
[10] Univ Bern, Inst Infect Dis, Mycobacteriol Unit, Bern, Switzerland
[11] Univ Zurich, Inst Med Microbiol, Natl Ctr Mycobacteria, Zurich, Switzerland
[12] Fed Off Publ Hlth, Div Communicable Dis, Bern, Switzerland
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS-INFECTION; RISK-FACTORS; ANTIRETROVIRAL TREATMENT; DISEASE PROGRESSION; INCOME COUNTRIES; 1ST YEAR; SWITZERLAND; EUROPE; SURVEILLANCE; MORTALITY;
D O I
10.1371/journal.pone.0034186
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups. The aim of this study was to compare characteristics of TB in HIV-negative and HIV-infected patients diagnosed in Switzerland, and between coinfected patients enrolled and not enrolled in the national Swiss HIV Cohort Study (SHCS). Methods and Findings: All patients diagnosed with culture-confirmed TB in the SHCS and a random sample of culture-confirmed cases reported to the national TB registry 2000-2008 were included. Outcomes were assessed in HIV-infected patients and considered successful in case of cure or treatment completion. Ninety-three SHCS patients and 288 patients selected randomly from 4221 registered patients were analyzed. The registry sample included 10 (3.5%) coinfected patients not enrolled in the SHCS: the estimated number of HIV-infected patients not enrolled in the SHCS but reported to the registry 2000-2008 was 146 (95% CI 122-173). Coinfected patients were more likely to be from sub-Saharan Africa (51.5% versus 15.8%, P<0.0001) and to present disseminated disease (23.9% vs. 3.4%, P, 0.0001) than HIV-negative patients. Coinfected patients not enrolled in the SHCS were asylum seekers or migrant workers, with lower CD4 cell counts at TB diagnosis (median CD4 count 79 cells/mu L compared to 149 cells/mu L among SHCS patients, P = 0.07). There were 6 patients (60.0%) with successful outcomes compared to 82 (88.2%) patients in the SHCS (P = 0.023). Conclusions: The clinical presentation of coinfected patients differed from HIV-negative TB patients. The number of HIV-infected patients diagnosed with TB outside the SHCS is similar to the number diagnosed within the cohort but outcomes are poorer in patients not followed up in the national cohort. Special efforts are required to address the needs of this vulnerable population.
引用
收藏
页数:5
相关论文
共 27 条
[1]   Early participation in an HIV cohort study slows disease progression and improves survival [J].
Battegay, M ;
Wirz, M ;
Steuerwald, MH ;
Egger, M .
JOURNAL OF INTERNAL MEDICINE, 1998, 244 (06) :479-487
[2]  
Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2
[3]   Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment [J].
Corbett, EL ;
Marston, B ;
Churchyard, GJ ;
De Cock, KM .
LANCET, 2006, 367 (9514) :926-937
[4]   Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission [J].
Elzi, Luigia ;
Schlegel, Matthias ;
Weber, Rainer ;
Hirschel, Bernard ;
Cavassini, Matthias ;
Schmid, Patrick ;
Bernasconi, Enos ;
Rickenbach, Martin ;
Furrer, Hansjakob .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) :94-102
[5]   Tuberculosis treatment outcomes in Europe: a systematic review [J].
Faustini, A ;
Hall, AJ ;
Perucci, CA .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) :503-510
[6]  
Federal Office of Public Health, 2011, B BAG
[7]  
Federal Office of Public Health, 2011, B BUNDESAMT GESUNDHE, P277
[8]  
Federal Office of Public Health, 2011, B BAG, P205
[9]   Tuberculosis in HIV programmes in lower-income countries: practices and risk factors [J].
Fenner, L. ;
Forster, M. ;
Boulle, A. ;
Phiri, S. ;
Braitstein, P. ;
Lewden, C. ;
Schechter, M. ;
Kumarasamy, N. ;
Pascoe, M. ;
Sprinz, E. ;
Bangsberg, D. R. ;
Sow, P. S. ;
Dickinson, D. ;
Fox, M. P. ;
McIntyre, J. ;
Khongphatthanayothin, M. ;
Dabis, F. ;
Brinkhof, M. W. G. ;
Wood, R. ;
Egger, M. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (05) :620-627
[10]  
Fenner L, 2011, J CLIN MICR IN PRESS